TL;DR
Get oils, diffusers and self-care delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A narrative review argues that neuropathic pain may be an overlooked part of recovery for some ICU survivors and calls for better diagnosis before considering new interventions. Neuromodulation methods such as nerve and spinal cord stimulation are proposed for future study, but their effectiveness after critical illness has not been established.
A narrative review by six clinicians argues that chronic neuropathic pain deserves closer attention in some people recovering from intensive care, while stressing that it must be distinguished from other causes of post-ICU pain. The authors say earlier, more specific diagnosis should come before testing neuromodulation treatments, whose effectiveness in this population has not been established.
The review, titled “Neuromodulation for Refractory Neuropathic Pain Following Critical Illness: A Narrative Review and Phenotype-Based Clinical Framework,” was published November 5, 2026. Its authors are Suresh Srinivasan, Kiran Khurshid, Uzam Hussain, Joseph Pathakamuri and Mohanraj Palani Selvam. They describe persistent pain as one of several challenges that can continue after an ICU stay, alongside weakness, mobility limitations, sleep problems, cognitive difficulties and psychological distress.
The article cites a 2026 meta-analysis estimating chronic pain incidence at about 47% three months after critical illness, 29% at six months and 31% at 12 months. Those figures refer to chronic pain overall, not specifically neuropathic pain. In a separate prospective multicenter cohort of 814 patients, nearly 48% reported significant persistent pain three months after ICU admission; of those reporting pain, about 9% screened positive for neuropathic symptoms. The authors caution that estimates vary with patient groups, definitions and follow-up periods.
The review distinguishes possible nerve-related pain from musculoskeletal pain, which may follow immobility, muscle injury, procedures or deconditioning. It also notes that critical illness polyneuropathy can affect sensory and motor nerves, while critical illness myopathy primarily affects muscle. Weakness alone is not evidence of neuropathic pain, the authors say. Rehabilitation, psychological support, sleep care and individualized medication remain part of recovery; medications can pose tolerability concerns for some patients, including those with cognitive impairment, renal dysfunction, dizziness, sedation or respiratory vulnerability.
Why Accurate Pain Diagnosis Matters
Recognizing a neuropathic component could help clinicians match care to the source and pattern of a survivor’s symptoms, rather than treating all persistent pain as the same condition. The distinction matters because post-ICU pain can arise from multiple causes, and an incorrect label may direct attention toward an unsuitable treatment while leaving other rehabilitation needs unaddressed.
The authors’ proposal is a research agenda, not a treatment recommendation supported by direct trials in ICU survivors. They suggest investigating peripheral nerve stimulation for localized nerve injuries, dorsal root ganglion stimulation for selected regional pain presentations, and spinal cord stimulation for certain broader patterns. These approaches could be relevant only for carefully selected patients with a clear diagnosis and target. The review does not establish that they work for pain following critical illness.
Products Worth Considering
Therabody Theragun Relief Massage Gun – Black
Theragun Relief Special Edition Bundle
Fitbit Versa 2 Health and Fitness Smartwatch with Heart Rate, Alexa, Music, Sleep and Swim Tracking
As an affiliate, we earn on qualifying purchases.
How the Review Frames ICU Recovery
Improved critical care has helped more people survive sepsis, respiratory failure and multi-organ dysfunction, but survival does not always mark the end of illness-related effects. Post-intensive care syndrome, or PICS, describes a range of physical, cognitive and psychological difficulties that may persist after an ICU admission. The review places chronic pain within that wider recovery picture and argues that the neuropathic subset has received less attention.
The authors refer to prior studies reporting persistent pain frequencies from 28% to 77%, a wide range they attribute to differences in populations, definitions and follow-up. They also discuss established neuromodulation research in other conditions. For example, the ACCURATE trial found higher three-month treatment success with dorsal root ganglion stimulation than conventional spinal cord stimulation in patients with lower-extremity complex regional pain syndrome or causalgia. The SENZA-PDN trial reported substantial pain relief with 10-kHz spinal cord stimulation in patients with refractory painful diabetic neuropathy. Those findings concern other patient groups and cannot establish benefit for ICU survivors.
“We need to identify neuropathic pain earlier, understand its underlying mechanisms, and investigate treatment strategies beyond conventional pharmacotherapy when symptoms remain disabling.”
— Suresh Srinivasan, Kiran Khurshid, Uzam Hussain, Joseph Pathakamuri and Mohanraj Palani Selvam, the review authors
Evidence Gaps in Post-ICU Pain
The available figures do not show how many ICU survivors have confirmed chronic neuropathic pain: most cited estimates measure persistent or chronic pain overall, while the cohort’s neuropathic figure comes from screening among participants reporting pain. Screening results do not by themselves establish a clinical diagnosis. The source material also does not specify a single diagnostic approach that has been validated for this population.
Most importantly, the review reports insufficient direct clinical evidence to determine whether peripheral nerve, dorsal root ganglion or spinal cord stimulation is effective for neuropathic pain after critical illness. Results from trials involving complex regional pain syndrome, causalgia or diabetic neuropathy cannot settle that question. The review is a narrative assessment and framework, not a clinical trial demonstrating benefit. Which patient profiles, if any, might benefit—and how risks compare with potential gains—remain open questions.
Research Before Wider Treatment
The authors call for better recognition of pain patterns and further study of the underlying nerve mechanisms in ICU survivors. Their proposed framework could help shape research that matches a suspected pain source to a possible stimulation target, but the source material does not identify a scheduled trial, recruitment plan or regulatory decision.
For now, the article supports careful clinical assessment and individualized recovery care, not routine neuromodulation after an ICU stay. Future studies would need to test these approaches directly in appropriately diagnosed patients and report both benefits and harms. Until such evidence is available, the review’s main message remains that diagnosis and targeted research should come before claims of treatment effectiveness.
Key Questions
How common is chronic pain after critical illness?
The review cites a 2026 meta-analysis estimating chronic pain in about 47% of patients at three months, 29% at six months and 31% at 12 months. These figures cover chronic pain broadly, not neuropathic pain specifically, and estimates differ across studies.
Does all pain after an ICU stay come from nerve damage?
No. Pain may be musculoskeletal or related to procedures, immobility, muscle injury or deconditioning, among other causes. The review says weakness alone does not establish neuropathic pain.
Is neuromodulation proven for ICU survivors?
No. The review discusses peripheral nerve, dorsal root ganglion and spinal cord stimulation as possible directions for research. It says there is insufficient direct clinical evidence to establish their effectiveness for neuropathic pain after critical illness.
What should recovery care include?
The review describes rehabilitation, physical therapy, psychological support, sleep care and individualized medication management as components of recovery. Clinicians need to assess the source of pain and consider a patient’s health and medication tolerability when planning care.
Source: medpagetoday.com
